When it completes its strategic process, MiddleBrook hopes to have a partner who can finance a pivotal test of timed-released Keflex, a version of another ...
... (15) successfully attract and retain collaborative partners, (16) successfully commercialize and gain market acceptance for its Keflex products, ...
While the company has been selling several doses of Keflex, a drug it bought from Eli Lilly & Co. in 2004, it sold the rights to that drug to investors to ...
The Company currently markets the Keflex brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
all 16 news articles
Currently, over 50% of cephalexin prescriptions are written by Primary Care Specialists which makes Keflex 750 mg a highly synergistic addition to Auriga's ...
... Inc. (ARGA) announced the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., pursuant to which Auriga will co-promote Keflex(R) ...
Currently, over 50% of cephalexin prescriptions are written by Primary Care Specialists which makes Keflex 750 mg a highly synergistic addition to Auriga's ...
Currently, over 50% of cephalexin prescriptions are written by Primary Care Specialists which makes Keflex(R) 750 mg a highly synergistic addition to ...
... Inc. (ARGA) announced the signing of a co-promotion agreement with MiddleBrook Pharmaceuticals, Inc., pursuant to which Auriga will co-promote Keflex(R) ...